This monograph focuses on real-world best practices for expanded treatment options beyond the traditional glaucoma therapy mainstays of prostaglandin analogues and -blockers. Experts in the field review the clinical and real-world data on ROCKi-based regimens for glaucoma, comparing monotherapy and combination therapy approaches for lowering IOP. The authors discuss a clinical case to highlight optimal use of these therapies in practice.
- Provider:Vindico Medical Education, LLC
- Activity Link: https://cme.healio.com/glaucomacme/practice-management/20240430/glaucoma-management-rising-out-of-the-darkness-and-into-the-light-with-rho-kinase-inhibitors/overview
- Start Date: 2024-04-30 05:00:00
- End Date: 2024-04-30 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 1.0 hours
- Commercial Support: Source: Alcon Vision, LLC. - Amount: 51742.5 - Is Kind Support: False
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: No, it's free
- Measured Outcome: Learner Knowledge, Learner/Team Competence
- Provider Ship: Directly Provided
- Registration: Open to all
Subscribe
Login
0 Comments
Oldest